908 DevicesMASS +2.87%70 Net Margin % is -89.34% as of Mar. 2026. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.91 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 817 Medical Devices & Instruments companies, 908 Devices ranks worse than 78.46% on this metric.
Net margin is calculated as Net Income divided by its Revenue. 908 Devices's Net Income for the
three
months ended in Mar. 2026 was $-11.96 Mil. 908 Devices's Revenue for the
three
months ended in Mar. 2026 was $13.38 Mil. Therefore, 908 Devices's net margin for the quarter that ended in Mar. 2026 was -89.34%.
The historical rank and industry rank for 908 Devices's Net Margin % or its related term are showing as below:
MASS'
s Net Margin % Range Over the Past 10 Years
Min: -151.23 Med: -62.09 Max: 34.68
Current: -62.4
MASS's Net Margin % is ranked worse than 78.46% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs MASS: -62.40
908 Devices (NAS:MASS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
908 Devices Net Margin % Related Terms
908 Devices Net Margin % Historical Data
* Premium members only.
The historical data trend for 908 Devices's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 908 Devices's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Net Margin % distribution charts can be found below:
* The bar in red indicates where 908 Devices's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a Net Margin % of -89.34% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #641 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 78.5%.
Is 908 Devices' Net Margin % too high?
908 Devices' current Net Margin % is -89.34%. Based on the distribution chart, 908 Devices ranks #641 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Net Margin % compare to ELMD and SI?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #641 out of 817 companies for Net Margin %. This places 908 Devices in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Net Margin % is -89.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.91, compared to a current price of $8.98 — trading 30% above its estimated fair value. The current Net Margin % is -89.34%. 908 Devices' overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For 908 Devices (MASS), the current Net Margin % is -89.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.98 is trading 30% above its estimated GF Value™ of $6.91.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
Net Margin %: -89.34%
GF Value™: $6.91 vs. price of $8.98 (30% above fair value)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
